UCL life sciences spin-out Magnus raises seed funding.

Duke biotech spin-out Argos wants to treble workforce and build a new facility.

Bill & Melinda Gates Foundation becomes the latest investor in the biotech with $5m.

The healthcare provider's $150m fund will target early-stage companies where its expertise can make a difference, according to senior executive Aaron Martin.

Drug therapeutics developer Avidity NanoMedicines has raised $6m in an EMS-backed series A round, adding to the $9m the company raised in February.

Imperial Innovations is investing in the oncology spin-out.

CleveXel Pharma is licensing two patents relating to diagnosis and treatment of myelodysplasia and leukaemia.